“Competitive Analysis of U.S. Pharmaceutical Industry, 2011” report is a detailed analysis of leading pharmaceutical companies in the U.S. pharmaceutical industry. Players analyzed in the report are - Pfizer, Merck, AstraZeneca, Novartis and Eli Lilly. Comparative analysis of companies is done on the basis of their sales and profits and other financial information. Detailed Ratio Analysis compares these companies on the basis of their revenue growth, profitability, efficiency, financial strength and investment returns. Report also presents a brief profile and SWOT Analysis of these companies along with their financial analysis and ratio analysis vis-à-vis industry. Lastly, report analyses the M&A activity in the U.S. Pharmaceutical Industry in recent years.